Health (Assisted Human Reproduction) Act 2024

PGT-M and PGT-SR

45. (1) An AHR treatment provider shall not provide PGT-M or PGT-SR except in accordance with section 47 or 48 where—

(a) the provider is satisfied, founded on a relevant opinion, that such provision is necessary to detect whether or not there is a significant risk of a child being born with a genetic disease the name of which is for the time being entered in the Register of Genetic Diseases, or

(b) such provision is for the purposes of HLA matching.

(2) In this section, “relevant opinion”, in relation to a risk referred to in subsection (1)(a), means the opinion in writing of a relevant specialist that there is such a risk.